1-10 of 10
P.Leif Bergsagel, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pomalidomide Plus Low-Dose Dexamethasone (Pom/Dex) in Relapsed Myeloma: Long Term Follow up and Factors Predicing Outcome in 345 Patients

Martha Q Lacy, MD, Shaji K. Kumar, MD, Betsy R. LaPlant, Kristina Laumann, Morie A Gertz, Suzanne R Hayman, MD, Francis K Buadi, M.D., Angela Dispenzieri, MD, John A. Lust, MD, PhD, Stephen Russell, MD, PhD, David Dingli, M.D., Ph.D., Steven R Zeldenrust, MD, PhD, Rafael Fonseca, MD, P.Leif Bergsagel, MD, Keith Stewart, MD, Vivek Roy, M.D., Taimur Sher, MD, Asher Chanan-Khan, MD, Craig Reeder, MD, S. Vincent Rajkumar, MD, Joseph R. Mikhael, MD
Journal: Blood
Blood (2012) 120 (21): 201.
https://doi.org/10.1182/blood.V120.21.201.201
Published: 2012
Journal Articles

Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of 225 Patients Treated in Five Cohorts Over Three Years,

Martha Q Lacy, MD, Betsy R. LaPlant, Kristina Laumann, Morie A Gertz, MD, Suzanne R Hayman, MD, Francis K Buadi, M.D., Angela Dispenzieri, MD, Shaji Kumar, MD, John A. Lust, MD, PhD, Stephen Russell, MD, PhD, David Dingli, M.D., Ph.D., Steven R Zeldenrust, MD, PhD, Philip R. Greipp, MD, Rafael Fonseca, MD, P.Leif Bergsagel, MD, Vivek Roy, M.D., Keith Stewart, MBA, MB, CHB, Craig B. Reeder, MD, Robert L Hall, RN, CNP, S. Vincent Rajkumar, MD, Joseph R. Mikhael, MD
Journal: Blood
Blood (2011) 118 (21): 3963.
https://doi.org/10.1182/blood.V118.21.3963.3963
Published: 2011
Journal Articles

Inhibition of c-Myc Expression and Function in Hematologic Malignancies

Ghayas C Issa, MD, Jake E Delmore, Michael R McKeown, Madeleine E Lemieux, Peter B Rahl, Hannah M. Jacobs, Efstathios Kastritis, MD, Timothy Gilpatrick, Ronald M Paranal, Jun Qi, Junwei Shi, Marta Chesi, Anna C. Schinzel, PhD, Christopher R. Vakoc, M.D., Ph.D., P.Leif Bergsagel, MD, Paul G. Richardson, MD, Richard Young, PhD, William C. Hahn, MD, PhD, Irene M. Ghobrial, MD, Kenneth C Anderson, MD, Andrew L. Kung, MD, PhD, Constantine S. Mitsiades, MD, PhD, James E Bradner, MD
Journal: Blood
Blood (2011) 118 (21): 1409.
https://doi.org/10.1182/blood.V118.21.1409.1409
Published: 2011
Journal Articles

Phase II Trial of Intravenously Administered AMD3100 (Plerixafor) for Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Following a Lenalidomide-Based Initial Therapy

Shaji Kumar, MD, Joseph R. Mikhael, MD, Martha Q Lacy, MD, Betsy R. LaPlant, Francis K Buadi, M.D., David Dingli, M.D., Ph.D., Morie A Gertz, MD, Teresa Miceli, RN, Marcia Mahlman, P.Leif Bergsagel, MD, Suzanne R Hayman, MD, Craig B. Reeder, MD, Angela Dispenzieri, MD, Dennis A. Gastineau, MD, Jeffrey Winters, MD
Journal: Blood
Blood (2011) 118 (21): 2992.
https://doi.org/10.1182/blood.V118.21.2992.2992
Published: 2011
Journal Articles

Generation of An Automated Tool for the Identification of Genetics Markers and Signatures in Multiple Myeloma Risk-Stratification

Esteban Braggio, PhD, Jonathan J Keats, PhD, Shaji Kumar, MD, Gregory Ahmann, BS, Jeremy Mantei, Keith Stewart, MBA, MB, CHB, P.Leif Bergsagel, MD, Rafael Fonseca, MD
Journal: Blood
Blood (2011) 118 (21): 2881.
https://doi.org/10.1182/blood.V118.21.2881.2881
Published: 2011
Journal Articles

Examining Measures of Proliferation for Use in Risk Stratification of Myeloma

Mark R.E. Coyne, MBBCh, BAO, MRCPI, Linda Wellik, Esteban Braggio, PhD, Michael E O'Dwyer, MD, FRCPI, FRCPath, Corrado Santocanale, PhD, Riccardo Valdez, MD, P.Leif Bergsagel, MD, Marta Chesi
Journal: Blood
Blood (2011) 118 (21): 5093.
https://doi.org/10.1182/blood.V118.21.5093.5093
Published: 2011
Journal Articles

Long Term Outcomes of Pomalidomide and Dexamethasone in Patients with Relapsed Multiple Myeloma: Analysis 4 Years After the Original Cohort

Joseph R. Mikhael, MD, Suzanne R Hayman, MD, Kristina Laumann, Vivek Roy, M.D., Betsy R. LaPlant, Shaji Kumar, MD, Francis K Buadi, M.D., Craig B. Reeder, MD, Morie A Gertz, MD, Angela Dispenzieri, MD, John A Lust, MD, PhD, A. Keith Stewart, MBA, MB, CHB, Stephen Russell, MD, PhD, P.Leif Bergsagel, MD, David Dingli, M.D., Ph.D., Steven Zeldenrust, MD, Rafael Fonseca, MD, Philip R. Greipp, MD, Robert L Hall, RN, CNP, S. Vincent Rajkumar, MD, Martha Q Lacy, MD
Journal: Blood
Blood (2011) 118 (21): 2942.
https://doi.org/10.1182/blood.V118.21.2942.2942
Published: 2011
Journal Articles

N-Methyl-2-Pyrrolidone Is a Biologically Active Thalidomide Subunit with In Vivo anti-Myeloma Properties

Jake Shortt, FRACP, FRCPA, Andy Hsu, PhD, Geoffrey M Matthews, PhD, Marta Chesi, P.Leif Bergsagel, MD, Grant A. McArthur, MD, PhD, FRACP, MBBS, Paul Neeson, PhD, David Ritchie, MBBS, FRACP, FRCPA, Ricky W Johnstone, PhD
Journal: Blood
Blood (2010) 116 (21): 4082.
https://doi.org/10.1182/blood.V116.21.4082.4082
Published: 2010
Journal Articles

Targeting the CD28-B7 Pro-Survival Pathway In Multiple Myeloma

Jayakumar Nair, Ph.D., Louise Carlson, Cheryl H Rozanski, BS, Chandana Koorella, Megan Murray, John Shaughnessy, Jr., PhD, P.Leif Bergsagel, MD, Lawrence H. Boise, PhD, Asher A. Chanan-Khan, Kelvin P Lee, MD
Journal: Blood
Blood (2010) 116 (21): 132.
https://doi.org/10.1182/blood.V116.21.132.132
Published: 2010
Journal Articles

The Combination of Cyclophosphamide-Bortezomib-Dexamethasone (CYBOR-D) Is a Highly Effective and Well Tolerated Regimen that Produces Rapid and Complete Hematological Response In Patients with AL Amyloidosis

Joseph R. Mikhael, MD, Steven R. Schuster, MD, Victor H Jimenez-Zepeda, MD, PD, Nancy Bello, Jacy Spong, Craig B. Reeder, MD, A. Keith Stewart, MD, P.Leif Bergsagel, MD, Rafael Fonseca
Journal: Blood
Blood (2010) 116 (21): 3063.
https://doi.org/10.1182/blood.V116.21.3063.3063
Published: 2010